The combination of CALR nanotide-modified EcN-215 and ICG reshaps the tumor microenvironment (TME) by enhancing the infiltration of CD45+CD3+ T cells and CD11b+F4/80+ macrophages. The gene discussed is CALR; the disease is neoplasm.